Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of LY900014 on Recovery From Hyperglycemia Compared to Humalog in Subjects With Type 1 Diabetes Mellitus (T1DM) on Continuous Subcutaneous Insulin Infusion

Next Previous
Search
Trial Profile

Effects of LY900014 on Recovery From Hyperglycemia Compared to Humalog in Subjects With Type 1 Diabetes Mellitus (T1DM) on Continuous Subcutaneous Insulin Infusion

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jan 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin lispro (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Eli Lilly and Company

    • Most Recent Events

    • 01 Jan 2024 Results comparing the time of recovery from hyperglycaemia following administration of URLi compared with Humalog in patients with type 1 diabetes on continuous subcutaneous insulin infusion, published in the Diabetes, Obesity and Metabolism.
    • 29 Jun 2021 Primary endpoint has not been met. (Time to Recovery from Hyperglycemia Following Administration of LY900014 and Insulin Lispro (Humalog), as per Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association
    • 29 Jun 2021 Primary endpoint has been met. (Time to Recovery from Hyperglycemia Following Administration of LY900014 and Insulin Lispro (Humalog), as per Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top